SNOA Stock Posts

SNOA Sonoma Pharmaceuticals7.43+0.58+8.5%

After Hours:9.23+1.80 (+24.2%)

Sonoma Pharmaceuticals and EMC Pharma Announce an Exclusive Partnership to Expand Commercial Channels of the Microcyn-based Rx Dermatology and Eye Care Products Nationwide

Business WireWed, 31-Mar 4:10 PM

SNOA Sonoma Pharmaceuticals7.43+0.58+8.5%

After Hours:9.11+1.68 (+22.6%)

Sonoma Pharmaceuticals and EMC Pharma Announce an Exclusive Partnership to Expand Commercial Channels of the Microcyn-based Rx Dermatology and Eye Care Products Nationwide

Business WireWed, 31-Mar 4:10 PM

SNOA Sonoma Pharmaceuticals7.63-0.47-5.8%

After Hours:9.77+2.14 (+28.1%)

ROSEN, RESPECTED INVESTOR COUNSEL, Continues Its Investigation of Securities Claims Against Sonoma Pharmaceuticals, Inc. SNOA

Globe NewswireThu, 17-Dec 6:17 PM

SNOA Sonoma Pharmaceuticals7.63-0.47-5.8%

After Hours:9.68+2.05 (+26.9%)

Sonoma Pharmaceuticals Announces Partnership with Gabriel Science, LLC For Dental Markets

Business WireThu, 17-Dec 4:10 PM

SNOA Sonoma Pharmaceuticals6.13-0.12-1.9%

After Hours:8.80+2.67 (+43.6%)

Sonoma Pharmaceuticals and Crown Laboratories Announce an Exclusive Partnership to Launch Microcyn Technology-Based Anti-Itch Over-the-Counter Products

Business WireThu, 10-Dec 4:10 PM

SNOA Sonoma Pharmaceuticals6.13-0.12-1.9%

After Hours:8.75+2.62 (+42.7%)

Sonoma Pharmaceuticals and Crown Laboratories Announce an Exclusive Partnership to Launch Microcyn Technology-Based Anti-Itch Over-the-Counter Products

Business WireThu, 10-Dec 4:10 PM